Drug Discovery Featured Articles & Applications

  1. Designing Drugs For Women: Closing The Therapeutic Gap 12/12/2025

    Women’s health remains underdeveloped in drug innovation. Growing momentum across policy, science, and funding creates an opportunity to better align drug discovery with women’s health needs.

  2. Small Cells, Big Shifts: Recent Advances In Targeting Small Cell Lung Cancer 12/11/2025

    Therapeutic progress in small cell lung cancer has been limited, with meaningful advances emerging only in the past two years. We discuss these new developments and consider the future treatment paradigm.

  3. CROs In Early Drug Discovery, Part 3: Budgets, Timelines, And Avoiding Pitfalls 12/10/2025

    Part 3 of this series covers managing budgets, timelines, and avoiding operational pitfalls.

  4. Rats Behind The Wheel: The Right Preclinical Way To Investigate Drug Effects On Driving? 12/8/2025

    What can we do preclinically for drug-induced impairment of driving ability? This article reviews the causes, regulatory environment, and limitations.

  5. Biotech Wasn't Ready For AI's Speed; Here's How We Catch Up 12/5/2025

    Computational success is no stand-in for therapeutic readiness. Innovators must learn to discern between models rooted in science and those that speculate.

  6. Strained Manufacturing, Complexity Stymie In Vivo Progress 12/4/2025

     Explicitly mapping delivery challenges to the associated GMP process steps converts biological risk into operational risk.

  7. To Fight Cancer, Gene Editing Needs To Solve Its Delivery Problem 12/4/2025

    The choice of delivery dictates the complexity of manufacturing, which in turn determines the eventual cost and accessibility of the therapy.

  8. Is Oncology Precision Medicine Coming of Age? 12/3/2025

    Developers are releasing new data suggesting that their targeted therapy candidates may finally address some of oncology’s toughest challenges.

  9. CROs In Early Drug Discovery, Part 2: Keeping Pace And Protecting Quality 12/3/2025

    Part 2 of this series covers how to maintain momentum and protect data quality.

  10. The Blue Crayfish: Turning Nature's Efficiency Into Safe, Bioavailable Therapeutics 12/1/2025

    Crayfish achieve incredibly rapid biomineralization — a physiological marvel that is now setting the stage for a new class of highly bioavailable mineral-based therapeutic agents.